Greetings from Future Medicine Education and Research Organization
At Chiba University’s Inohana Campus, a comprehensive assembly of academic and clinical institutions—including the Faculties of Medicine, Pharmaceutical Sciences, and Nursing, their respective graduate schools, the University Hospital, the Medical Mycology Research Center, and the Synergy Institute for Futuristic Mucosal Vaccines Research and Development (cSIMVa)—collectively constitute an ideal environment for advancing the frontiers of medical research and fostering the next generation of healthcare professionals.
Within this distinguished setting, we are presently advancing the “Inohana Campus High-Functionality Initiative for the Cultivation of Next-Generation Medical Professionals and the Establishment of a Hub for Therapeutics”—a strategic vision aimed at responding to the increasingly diverse demands of future healthcare. Our ultimate objective is to nurture medical professionals who will contribute to the realization of a society characterized by health, longevity, safety, and well-being. The Future Medicine Education and Research Organization at Chiba University (hereinafter referred to as “the Organization”) is entrusted with the critical responsibility of serving as the command center for the materialization of this vision.
The Organization is steadfastly committed to the reform of research governance, the advancement of financial autonomy in academic inquiry, and the establishment of a vibrant research environment wherein young investigators, physician-scientists, and international researchers may engage in their pursuits with vigor and creativity.
Since the commencement of the 2023 academic year, the Organization has assumed a central role in the implementation of the Program for Forming Japan’s Peak Research Universities “J-PEAKS”—an endeavor to support research universities to establish both hardware and software environments necessary to accelerate and elevate internationalization and social implementation of research activities, under their management strategy based on their unique research strengths and characteristics, with the aim of dramatically improving their research capabilities. The Organization provides robust support to two cornerstone centers: the Center for Human Immunological Diseases and Therapy Development (cCHID) and the Next Generation In Vivo Research Exploratory Center (cNIVR), thereby further propelling therapeutic science across the Inohana Campus. Moreover, in close partnership with the Academic Research & Innovation Management Organization: IMO, the Organization is actively engaged in initiatives to secure external funding and to advance the societal implementation of research achievements, through the dedicated efforts of University Research Administrators and other research management professionals.
I extend my deepest appreciation for your continued understanding, encouragement, and guidance toward the activities of the Future Medicine Education and Research Organization at Chiba University. It is our sincere hope that we may count on your unwavering support as we endeavor to fulfill our mission.
With the highest regards,
Hiroshi Nakajima, M.D., Ph.D.
Director, Future Medicine Education and Research Organization at Chiba University
